SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)
88.70
-1.50 (-1.66%)
May 13, 2025, 1:30 PM CST
SYN-TECH Chem. & Pharm. Revenue
SYN-TECH Chem. & Pharm. had revenue of 315.75M TWD in the quarter ending March 31, 2025, with 17.04% growth. This brings the company's revenue in the last twelve months to 1.30B, up 16.69% year-over-year. In the year 2024, SYN-TECH Chem. & Pharm. had annual revenue of 1.26B with 12.83% growth.
Revenue (ttm)
1.30B
Revenue Growth
+16.69%
P/S Ratio
3.04
Revenue / Employee
5.74M
Employees
227
Market Cap
3.96B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.26B | 142.98M | 12.83% |
Dec 31, 2023 | 1.11B | 128.39M | 13.02% |
Dec 31, 2022 | 986.30M | 93.07M | 10.42% |
Dec 31, 2021 | 893.23M | -90.56M | -9.20% |
Dec 31, 2020 | 983.79M | 37.38M | 3.95% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 11.34B |
Caliway Biopharmaceuticals | 40.47M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 19.12B |
Polaris Group | 107.00M |
Oneness Biotech | 117.93M |
Pegavision | 6.69B |
Lumosa Therapeutics | 43.59M |